| Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipient (NCT03256864) | Chang Gung Memorial Hospital | 2016-01-01 |
| Tumor Characteristics, Pre-transplant Treatments and Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma (NCT02995096) | Rigshospitalet, Denmark | 2016-01-01 |
| Evaluation of Donor Specific Immune Senescence and Exhaustion as Biomarkers of Tolerance Post Liver Transplantation (NCT02533180) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-12-15 |
| Incidence of Intracranial Hypertension During Liver Transplantation Estimated by Non-invasive Ultrasound Methods. (NCT02695823) | Hospices Civils de Lyon | 2015-12-09 |
| Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation (NCT02877628) | Rennes University Hospital | 2015-10-31 |
| Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients. (NCT03596970) | Novartis Pharmaceuticals | 2015-09-01 |
| Propofol Versus Dexmedetomidine for Prevention of Sevoflurane Agitation in Recipients of Living Donor Liver Transplantation (NCT02544906) | AlRefaey Kandeel | 2015-09-01 |
| Association of Genetic Polymorphism and Acute Kidney Injury After Liver Transplantation (NCT02489474) | Yonsei University | 2015-07-10 |
| To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients (NCT04761731) | Linical Korea | 2015-07-01 |
| Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC) (NCT02898415) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-06-01 |
| A Study of Retrograde rEperfusion in Dbd Donor LIver Transplantation (NCT02423941) | Republican Scientific and Practical Center for Organ and Tissue Transplantation | 2015-04-01 |
| Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation (NCT02417207) | Third Affiliated Hospital, Sun Yat-Sen University | 2015-04-01 |
| Validity of Different Prognostic Models Assessing 1 Year Survival After Liver Transplantation (NCT02412280) | Mansoura University | 2015-04-01 |
| Evaluation of Liver Grafts With FibroScan® Before Organ Retrieval in Patients With Brain Death (NCT02460250) | University Hospital, Limoges | 2015-02-01 |
| Data Collection Study From Donors and Recipients to Optimize Donor-recipient Matching in Liver Transplantation (NCT03371264) | Assistance Publique - Hôpitaux de Paris | 2015-01-01 |
| Research and Application for New Clinical Diagnosis and Treatment System for HBV Related HCC Liver Transplantation (NCT06409507) | First People's Hospital of Hangzhou | 2015-01-01 |
| Role of Human Leukocyte Antigen Matching in Liver Transplantation and Its Relation to Outcomes (NCT03094728) | Ain Shams University | 2015-01-01 |
| Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation (NCT07418138) | Hu Liangshuo | 2015-01-01 |
| Prognosis Analysis of Elderly Donor Liver in Liver Transplantation (NCT05355662) | First Affiliated Hospital Xi'an Jiaotong University | 2015-01-01 |
| The Favorable Impact of HBcAb Positive Grafts on Liver Transplantation for HBV-related HCC (NCT06787534) | Xiao Xu | 2015-01-01 |
| Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation (NCT02188719) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-12-17 |
| Non-Invasive Assessment of Graft Fibrosis After Living Donor Liver Transplantation (NCT03176290) | Ain Shams University | 2014-12-01 |
| Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment. (NCT02352181) | Hospices Civils de Lyon | 2014-12-01 |
| Efficacy of Low-dose Dexmedetomidine to Prevent Delirium in Liver Transplant Patients (NCT02245256) | Seoul National University Hospital | 2014-09-01 |
| Early Treatment of Recurrent HCV- Infection Post Liver Transplantation in the Era of DAAs (NCT03133065) | Ain Shams University | 2014-09-01 |
| Immunosuppression and Diet: the Role of Inflammation in the Adipose Tissue Remodeling (NCT03103984) | Federal University of Minas Gerais | 2014-07-01 |
| A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year (NCT02143479) | Astellas Pharma S.A.S. | 2014-06-18 |
| Mediterranean Diet and Protein-Sparing Modified Diet for Metabolic Syndrome in Liver Transplant Recipients (NCT02174783) | The Cleveland Clinic | 2014-06-01 |
| Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver Transplantation (NCT03665766) | Ain Shams University | 2014-05-15 |
| REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy (NCT02115113) | Novartis Pharmaceuticals | 2014-03-28 |
| Therapeutic Strategy and the Role of Mesenchymal Stromal Cells for ABO Incompatible Liver Transplantation (NCT02706132) | Third Affiliated Hospital, Sun Yat-Sen University | 2014-02-01 |
| Incidence, Risk Factors, and Risk Model of Acute Kidney Injury After Liver Transplantation (NCT02080065) | Samsung Medical Center | 2014-01-01 |
| Research on Using Small-for-size Grafts for Auxiliary Liver Transplantation in the Treatment of Portal Hypertension (NCT07247877) | Zhi-Jun Zhu | 2014-01-01 |
| Sugammadex/Neostigmine and Liver Transplantation (NCT02697929) | Azienda Ospedaliera S. Maria della Misericordia | 2014-01-01 |
| Use of Direct-acting Antiviral to Treat HCV Recurrence After Liver Transplantation (ANRSCO23CUPILT) Infection (NCT01944527) | ANRS, Emerging Infectious Diseases | 2013-10-01 |
| Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants (NCT01888432) | Novartis Pharmaceuticals | 2013-09-25 |
| Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus (NCT01887171) | Republican Scientific and Practical Center for Organ and Tissue Transplantation | 2013-07-01 |
| Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation (NCT01909401) | Indiana University | 2013-06-01 |
| Evaluation of Liver Disease With Elastography Measurements in Patients Undergoing Liver Transplant Surgery (NCT01890460) | Baylor Research Institute | 2013-06-01 |
| Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver Transplantation (NCT01836718) | Schiano, Thomas D., MD | 2013-06-01 |
| Perioperative Evaluation of Terlipressin Infusion During Living Donor Liver Transplantation on Incidence of Acute Kidney (NCT02059460) | National Liver Institute, Egypt | 2013-05-01 |
| Safety Study of Multipotent Progenitor Cells for Immunomodulation Therapy After Liver Transplantation (NCT01841632) | Prof. Dr. Marc-H. Dahlke, Ph. D. | 2013-04-01 |
| Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression. (NCT01824368) | Red de Terapia Celular | 2013-04-01 |
| Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase Inhibitor in Liver Transplantation (NCT05448339) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2013-01-01 |
| Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients (NCT01781871) | Helsinki University Central Hospital | 2013-01-01 |
| A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients (NCT01625377) | Novartis Pharmaceuticals | 2012-12-01 |
| Comparison of PRS According to Inhalation Agent During LDLT (NCT01886664) | Seoul National University Hospital | 2012-12-01 |
| Study of Covalently Closed Circular DNA (cccDNA) in Liver Transplant Patients With B Virus Markers (NCT02602847) | Hospices Civils de Lyon | 2012-11-01 |
| Organ Transplantation Rehabilitation: Effect of Bedside Exercise Device and Activity Reinforcement (NCT01705015) | National Taiwan University Hospital | 2012-09-01 |
| Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients (NCT01638559) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-14 |
| Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients (NCT01672164) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-08-01 |
| Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients (NCT01551212) | Novartis Pharmaceuticals | 2012-05-24 |
| Acoustic Radiation Force Impulse Imaging (ARFI) in Patients After Liver Transplantation (NCT01664780) | University of Erlangen-Nürnberg Medical School | 2012-05-01 |
| A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time (NCT01614665) | Astellas Pharma Europe Ltd. | 2012-04-03 |
| A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India (NCT02432053) | Astellas Pharma Inc | 2012-03-01 |
| Supplements SMOF in TPN for Liver Transplantation Recipients (NCT04572373) | Chang Gung Memorial Hospital | 2012-01-01 |
| Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma (NCT07703735) | Seoung Hoon Kim | 2012-01-01 |
| Long-Term Outcomes of ABO-Incompatible Versus Compatible Living Donor Liver Transplantation (NCT07105085) | Seoung Hoon Kim | 2012-01-01 |
| Effect of Rapid Transfusion With Fluid Management System 2000® (FMS) (NCT01448343) | Seoul National University Hospital | 2011-10-01 |
| Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance (NCT01445236) | Hospital Clinic of Barcelona | 2011-09-01 |
| Autoregulation Assessment During Liver Transplantation (NCT01425385) | Johns Hopkins University | 2011-09-01 |
| Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation (NCT01655563) | The Hospital for Sick Children | 2011-09-01 |
| Gene Expression in Liver Allograft Rejection and Recurrent Hepatitis C (NCT01428700) | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-08-01 |
| A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients (NCT01371344) | Astellas Pharma Europe Ltd. | 2011-06-24 |
| A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation (NCT01371331) | Astellas Pharma Europe Ltd. | 2011-06-09 |
| CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation (NCT01023542) | University of Regensburg | 2011-06-01 |
| Vecuronium Requirements According to the Operation Phase During Liver Transplantation Under Desflurane Anesthesia (NCT01379352) | Samsung Medical Center | 2011-06-01 |
| Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf® (NCT01294020) | Astellas Pharma Europe Ltd. | 2011-05-25 |
| A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation (NCT01339468) | Astellas Pharma Inc | 2011-04-27 |
| Endotracheal Cardiac Output Monitor (ECOM) for Patients Undergoing Liver Transplantation (NCT01299441) | Mayo Clinic | 2011-02-01 |
| Search for Transcriptional Biomarkers in a Conversion Protocol From Calcineurin Inhibitors to Mycophenolate Mofetil (NCT01321112) | Pontificia Universidad Catolica de Chile | 2011-02-01 |
| Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation (NCT02123108) | University of California, Los Angeles | 2011-01-01 |
| The Predictors for Continuous Renal Replacement Therapy in Liver Transplant Patient (NCT01457534) | Yonsei University | 2011-01-01 |
| Postoperative Complications After Liver Transplantation (NCT02761109) | Azienda Ospedaliera S. Maria della Misericordia | 2011-01-01 |
| Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients (NCT01131065) | Instituto Grifols, S.A. | 2010-07-01 |
| Withdrawal of Immunosuppression in Long Term Stable Liver Transplant Recipients (NCT01198314) | The Catholic University of Korea | 2010-07-01 |
| Study in Hepatitis C Virus (HCV) Infected Patients Undergoing Liver Transplantation to Evaluate a Human Monoclonal Antibody Against Hepatitis C (NCT01121185) | MassBiologics | 2010-06-01 |
| The Immune Tolerance Mechanism Induced by IL-17-producing Regulatory T Cells in the Orthotopic Liver Transplant Recipients With Aspergillosis (NCT01117077) | Shanghai Jiao Tong University School of Medicine | 2010-05-01 |
| Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients (NCT01128335) | Novartis Pharmaceuticals | 2010-04-01 |
| Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy (NCT01197573) | The Cleveland Clinic | 2010-04-01 |
| An Observational Study to Assess the Effect of Calcineurin Inhibitors on Markers of Transplant Tolerance (NCT01065584) | University Medical Center Goettingen | 2010-02-01 |
| Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation (NCT00890253) | Armin Goralczyk | 2010-01-01 |
| Impact of Delta Model of End Stage Liver Disease (MELD) in High MELD Liver Transplant Recipients (NCT07570901) | University of Jena | 2010-01-01 |
| Post-Operative Use of Salt Poor Albumin Solution in Resuscitation of Orthotopic Liver Transplant (NCT00842803) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2010-01-01 |
| Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients (NCT01654848) | CHIR-Net | 2010-01-01 |
| Liver Transplant European Study Into the Prevention of Fungal Infection (NCT01058174) | Astellas Pharma Inc | 2009-12-15 |
| Effect of Rapamycin on Tolerance-related Biomarkers on Stable Liver Transplant Recipients (NCT01034345) | Hospital Clinic of Barcelona | 2009-11-01 |
| Effect of Nitric Oxide (NO) on Ischemic/Reperfusion Injury During Extended Donor Criteria (EDC) Liver Transplantation (NCT00948194) | University of Colorado, Denver | 2009-10-01 |
| Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation (NCT01011205) | Astellas Pharma Inc | 2009-09-30 |
| Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C (NCT00938860) | Novartis Pharmaceuticals | 2009-09-01 |
| Prophylaxis of Hepatitis B Virus Recurrence After Liver Transplantation (NCT01139203) | Shanghai Jiao Tong University School of Medicine | 2009-08-01 |
| Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant (NCT00970073) | The Cleveland Clinic | 2009-08-01 |
| Intact Liver Innervation and Glucose and Glucagon-like Peptide-1 (GLP-1) Induced Insulin Secretion (NCT01176708) | University Hospital, Gentofte, Copenhagen | 2009-07-01 |
| A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients (NCT01018914) | Astellas Pharma Inc | 2009-04-01 |
| Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus (NCT00909571) | Astellas Pharma Inc | 2009-04-01 |
| Surgical Site Infections After Liver Transplantation Based on Perioperative Antibiotics (NCT02717273) | University of Virginia | 2009-03-01 |
| Effect of Nafamostat on Postreperfusion Syndrome (PRS) (NCT01001403) | Seoul National University Hospital | 2009-03-01 |
| Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols (NCT00839709) | University of Washington | 2009-03-01 |
| Impact of Postoperative Adjuvant Chemotherapy in Patients With Hepatocellular Carcinoma After Liver Transplantation (NCT01125020) | Shanghai Jiao Tong University School of Medicine | 2008-12-01 |
| Quality of Life in Pediatric Transplant Patients (NCT00678002) | Medical College of Wisconsin | 2008-10-01 |